BSE Live
Dec 10, 16:01Prev. Close
6292.20
Open Price
6293.05
Bid Price (Qty.)
6286.55 (2)
Offer Price (Qty.)
6400.00 (1)
NSE Live
Dec 10, 14:59Prev. Close
6294.00
Open Price
6294.00
Bid Price (Qty.)
6310.50 (5)
Offer Price (Qty.)
6312.00 (1)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,813.29 | 1,833.23 | 1,219.36 | 1,388.23 | 1,371.84 | |
| Net CashFlow From Operating Activities | 1,208.47 | 964.06 | 764.72 | 1,149.11 | 1,032.40 | |
| Net Cash Used In Investing Activities | -81.38 | -684.24 | -475.89 | -1,137.41 | -413.43 | |
| Net Cash Used From Financing Activities | -1,091.25 | -245.94 | -314.17 | 3.27 | -624.14 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 35.84 | 33.88 | -25.34 | 14.97 | -5.17 | |
| Cash And Cash Equivalents Begin of Year | -7.96 | -41.84 | -16.50 | -31.47 | 9.06 | |
| Cash And Cash Equivalents End Of Year | 27.88 | -7.96 | -41.84 | -16.50 | 3.89 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill